Lipocine Management

Dr. Mahesh V. Patel has more than 20 years of technology and product development experience in the area of drug discovery support, drug delivery and product line extensions. Prior to co-founding Lipocine in 1997, Dr. Patel led drug delivery research and development at Pharmacia and Upjohn in Kalamazoo, MI. He received his MS in Physical Pharmacy at the University of Cincinnati and his PhD in Pharmaceutics from the University of Utah. His areas of expertise include strategic planning, technology assessment/development, technical management and product research and development.

MAHESH V. PATEL, PH.D.

PRESIDENT AND CHIEF EXECUTIVE OFFICER
Dr. Mahesh V. Patel has more than 20 years of technology and product development experience in the area of drug discovery support, drug delivery and product line extensions. Prior to co-founding Lipocine in 1997, Dr. Patel led drug delivery research and development at Pharmacia and Upjohn in Kalamazoo, MI. He received his MS in Physical Pharmacy at the University of Cincinnati and his PhD in Pharmaceutics from the University of Utah. His areas of expertise include strategic planning, technology assessment/development, technical management and product research and development.
Ms. Fogarty has served as Lipocine’s Corporate Controller since October 2018. Ms. Fogarty previously served as Chief Financial Officer at Alternative Behavior Strategies, a provider of ABA therapy services, as Controller and Associate VP Business Operations at Navigen, a pharmaceutical discovery and drug development company, and as VP Finance at Lineagen, a personal genomics and biotechnology company. Ms. Fogarty also previously served as Corporate Controller at NPS Pharmaceuticals, a biotechnology company. Ms. Fogarty received a B.S. in Accounting from Utah State University and also received a MAcc from Utah State University.

KRISTA FOGARTY

PRINCIPAL ACCOUNTING OFFICER AND CORPORATE CONTROLLER
Ms. Fogarty has served as Lipocine’s Corporate Controller since October 2018. Ms. Fogarty previously served as Chief Financial Officer at Alternative Behavior Strategies, a provider of ABA therapy services, as Controller and Associate VP Business Operations at Navigen, a pharmaceutical discovery and drug development company, and as VP Finance at Lineagen, a personal genomics and biotechnology company. Ms. Fogarty also previously served as Corporate Controller at NPS Pharmaceuticals, a biotechnology company. Ms. Fogarty received a B.S. in Accounting from Utah State University and also received a MAcc from Utah State University.
Dr. Anthony DelConte has over 25 years of experience in the healthcare industry. Currently, he is an Assistant Professor of Pharmaceutical and Healthcare Marketing at Saint Joseph's University and founder of DC Medical Consulting LLC, an advisory and consulting firm focusing on clinical development, medical affairs, and drug safety activities. Previously Dr. DelConte was Chief Medical Officer at Auxilium Pharmaceuticals (NASDAQ: AUXL), and held positions of increasing responsibility at Wyeth, now Pfizer (NYSE: PFE) and Novartis Pharmaceuticals (NYSE: NVS). He also served on the faculty at Jefferson Medical College of Thomas Jefferson University. Dr. DelConte holds a Bachelor of Science in Biology from Saint Joseph's University and earned his Medical Degree from the University of Pittsburgh. He is a fellow of the American College of Obstetricians and Gynecologists and a Diplomat of the American Board of Obstetrics and Gynecology. He currently serves as President of the Medical Alumni Association at Saint Joseph’s University.

ANTHONY DELCONTE, M.D.

CHIEF MEDICAL DIRECTOR
Dr. Anthony DelConte has over 25 years of experience in the healthcare industry. Currently, he is an Assistant Professor of Pharmaceutical and Healthcare Marketing at Saint Joseph's University and founder of DC Medical Consulting LLC, an advisory and consulting firm focusing on clinical development, medical affairs, and drug safety activities. Previously Dr. DelConte was Chief Medical Officer at Auxilium Pharmaceuticals (NASDAQ: AUXL), and held positions of increasing responsibility at Wyeth, now Pfizer (NYSE: PFE) and Novartis Pharmaceuticals (NYSE: NVS). He also served on the faculty at Jefferson Medical College of Thomas Jefferson University. Dr. DelConte holds a Bachelor of Science in Biology from Saint Joseph's University and earned his Medical Degree from the University of Pittsburgh. He is a fellow of the American College of Obstetricians and Gynecologists and a Diplomat of the American Board of Obstetrics and Gynecology. He currently serves as President of the Medical Alumni Association at Saint Joseph’s University.
Dr. Chidu Chidambaram has more than 20 years of experience in research and development in drug delivery, product development and associated line extensions. Prior to joining Lipocine, Dr. Chidambaram was actively involved in product development at Banner Pharmacaps Inc., (now, Thermo Fisher) in High Point, NC. During his tenure at Banner, he was responsible for bringing several products from research to commercial. He received his master’s in pharmacy from Institute of Technology, Banaras Hindu University in India, and PhD in Pharmaceutics from the University of Connecticut. His area of expertise includes strategizing product development from a technical aspect, which includes product development and management in terms of formulation, analytical, clinical, regulatory, and intellectual properties.

CHIDU CHIDAMBARAM, PH.D.

VP PRODUCT DEVELOPMENT
Dr. Chidu Chidambaram has more than 20 years of experience in research and development in drug delivery, product development and associated line extensions. Prior to joining Lipocine, Dr. Chidambaram was actively involved in product development at Banner Pharmacaps Inc., (now, Thermo Fisher) in High Point, NC. During his tenure at Banner, he was responsible for bringing several products from research to commercial. He received his master’s in pharmacy from Institute of Technology, Banaras Hindu University in India, and PhD in Pharmaceutics from the University of Connecticut. His area of expertise includes strategizing product development from a technical aspect, which includes product development and management in terms of formulation, analytical, clinical, regulatory, and intellectual properties.
Scroll to Top